US Stock MarketDetailed Quotes

CTKB Cytek Biosciences

Watchlist
  • 6.150
  • -0.090-1.44%
Trading Dec 19 12:12 ET
792.19MMarket Cap-76.88P/E (TTM)

Cytek Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
411.89%13.22M
317.68%6.2M
38.45%3.96M
143.18%5.28M
53.59%9.51M
43.51%-4.24M
69.81%-2.85M
293.11%2.86M
-364.17%-12.23M
13.67%6.19M
Net income from continuing operations
114.56%940K
-137.78%-10.43M
9.37%-6.17M
-589.05%-12.15M
48.01%5.5M
-497.05%-6.46M
-525.07%-4.39M
-215.43%-6.81M
-17.94%2.48M
419.14%3.72M
Operating gains losses
19.82%-1.25M
44.54%-1.18M
26.90%-1.16M
-8,541.56%-6.65M
---1.4M
---1.55M
---2.12M
---1.58M
-92.50%-77K
----
Depreciation and amortization
9.77%2.81M
1.43%2.48M
36.59%2.46M
63.10%9.23M
30.10%2.43M
231.91%2.56M
57.34%2.45M
22.52%1.8M
355.64%5.66M
172.12%1.86M
Other non cash items
-86.46%65K
-49.13%146K
-44.67%301K
-27.59%1.58M
-53.09%266K
-14.89%480K
-47.72%287K
9.24%544K
10.39%2.18M
-25.20%567K
Change In working capital
161.85%3.26M
259.15%8.11M
-49.99%1.85M
73.68%-10.51M
19.01%-3.84M
64.87%-5.27M
66.01%-5.09M
171.01%3.69M
-361.81%-39.93M
-336.17%-4.74M
-Change in receivables
8.73%-6.25M
187.03%5.92M
-30.06%4.24M
62.86%-7.33M
103.30%263K
-79.51%-6.85M
1.82%-6.8M
683.33%6.06M
-59.65%-19.74M
-1,006.11%-7.96M
-Change in inventory
288.35%3.56M
46.12%4.43M
249.72%4.77M
124.28%4.29M
236.15%6.33M
63.57%-1.89M
135.91%3.03M
46.16%-3.19M
-149.76%-17.65M
184.48%1.88M
-Change in prepaid assets
-413.33%-2.61M
214.34%3.47M
-2,050.74%-2.93M
50.86%-9.52M
-65.91%-7.18M
113.07%833K
29.68%-3.03M
96.87%-136K
-209.69%-19.36M
-246.16%-4.33M
-Change in payables and accrued expense
284.64%7.86M
-52.03%-5.31M
-292.65%-3.98M
-111.31%-1.06M
-144.86%-1.68M
336.85%2.04M
-211.78%-3.49M
-38.03%2.07M
-12.96%9.33M
-54.11%3.73M
-Change in other current liabilities
-17.28%-1.06M
23.24%-436K
24.88%-794K
-78.50%-3.41M
9.88%-885K
-35.79%-903K
-24.56%-568K
-653.40%-1.06M
48.23%-1.91M
81.49%-982K
-Change in other working capital
17.86%1.76M
-99.31%40K
1,206.12%542K
-30.72%6.52M
-123.88%-696K
-21.23%1.5M
186.07%5.77M
-101.90%-49K
-6.00%9.41M
-13.63%2.92M
Cash from discontinued investing activities
Operating cash flow
411.89%13.22M
317.68%6.2M
38.45%3.96M
143.18%5.28M
53.59%9.51M
43.51%-4.24M
69.81%-2.85M
293.11%2.86M
-364.17%-12.23M
13.67%6.19M
Investing cash flow
Cash flow from continuing investing activities
-136.66%-15.81M
-27.53%2.02M
96.59%-5.75M
-67.94%-93.89M
156.92%29.07M
3,849.91%43.12M
195.71%2.79M
-21,550.51%-168.87M
-166.32%-55.91M
-179.10%-51.06M
Net PPE purchase and sale
25.56%-990K
25.59%-977K
-12.28%-567K
52.32%-4.65M
77.03%-1.5M
-19.82%-1.33M
1.13%-1.31M
35.26%-505K
-123.37%-9.75M
-403.86%-6.53M
Net intangibles purchase and sale
112.70%8K
-169.09%-148K
---55K
-49.17%-179K
23.75%-61K
-57.50%-63K
---55K
--0
---120K
---80K
Net business purchase and sale
--0
--0
--0
---45.13M
---1K
---1K
--0
---45.13M
--0
--0
Net investment purchase and sale
-133.31%-14.83M
-24.31%3.15M
95.84%-5.13M
4.57%-43.94M
168.90%30.63M
--44.52M
362.00%4.16M
---123.24M
---46.04M
---44.45M
Cash from discontinued investing activities
Investing cash flow
-136.66%-15.81M
-27.53%2.02M
96.59%-5.75M
-67.94%-93.89M
156.92%29.07M
3,849.91%43.12M
195.71%2.79M
-21,550.51%-168.87M
-166.32%-55.91M
-179.10%-51.06M
Financing cash flow
Cash flow from continuing financing activities
-46.05%-12.08M
-892.13%-1.71M
1.61M
-858.43%-41.81M
-976.73%-33.75M
-5,438.06%-8.27M
-81.12%216K
0
-97.42%5.51M
22,547.06%3.85M
Net issuance payments of debt
2.17%-135K
-0.71%-142K
959.59%1.26M
-119.26%-565K
-104.77%-140K
---138K
---141K
---146K
205.81%2.93M
--2.93M
Net common stock issuance
-41.79%-11.95M
----
----
---44.15M
---34.74M
---8.43M
----
----
--0
--0
Proceeds from stock option exercised by employees
-66.67%147K
-15.04%1.23M
149.26%506K
19.15%3.32M
24.49%1.23M
95.13%441K
19.65%1.45M
-44.23%203K
334.42%2.79M
5,711.76%988K
Net other financing activities
2.01%-146K
-17.12%-130K
-159.65%-148K
-100.48%-419K
-43.66%-102K
-109.86%-149K
---111K
---57K
---209K
---71K
Cash from discontinued financing activities
Financing cash flow
-46.05%-12.08M
-892.13%-1.71M
--1.61M
-858.43%-41.81M
-976.73%-33.75M
-5,438.06%-8.27M
-81.12%216K
--0
-97.42%5.51M
22,547.06%3.85M
Net cash flow
Beginning cash position
35.25%177.92M
27.76%169.14M
-44.03%167.63M
-17.86%299.5M
-52.09%163.63M
-62.40%131.54M
-63.48%132.39M
-17.86%299.5M
119.49%364.62M
-9.36%341.52M
Current changes in cash
-147.93%-14.67M
4,076.28%6.52M
99.89%-184K
-108.26%-130.43M
111.76%4.82M
460.17%30.61M
101.39%156K
-8,656.12%-166.02M
-131.76%-62.63M
-219.70%-41.02M
Effect of exchange rate changes
-163.98%-943K
324.85%2.26M
255.50%1.7M
41.99%-1.45M
17.86%-823K
1,051.56%1.47M
28.19%-1.01M
-404.63%-1.09M
-291.17%-2.49M
-247.79%-1M
End cash Position
-0.81%162.3M
35.25%177.92M
27.76%169.14M
-44.03%167.63M
-44.03%167.63M
-52.09%163.63M
-62.40%131.54M
-63.48%132.39M
-17.86%299.5M
-17.86%299.5M
Free cash flow
316.94%12.22M
218.61%5M
41.73%3.34M
102.05%454K
2,006.71%7.95M
34.92%-5.63M
60.83%-4.22M
204.12%2.35M
-8,407.89%-22.1M
-110.04%-417K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 411.89%13.22M317.68%6.2M38.45%3.96M143.18%5.28M53.59%9.51M43.51%-4.24M69.81%-2.85M293.11%2.86M-364.17%-12.23M13.67%6.19M
Net income from continuing operations 114.56%940K-137.78%-10.43M9.37%-6.17M-589.05%-12.15M48.01%5.5M-497.05%-6.46M-525.07%-4.39M-215.43%-6.81M-17.94%2.48M419.14%3.72M
Operating gains losses 19.82%-1.25M44.54%-1.18M26.90%-1.16M-8,541.56%-6.65M---1.4M---1.55M---2.12M---1.58M-92.50%-77K----
Depreciation and amortization 9.77%2.81M1.43%2.48M36.59%2.46M63.10%9.23M30.10%2.43M231.91%2.56M57.34%2.45M22.52%1.8M355.64%5.66M172.12%1.86M
Other non cash items -86.46%65K-49.13%146K-44.67%301K-27.59%1.58M-53.09%266K-14.89%480K-47.72%287K9.24%544K10.39%2.18M-25.20%567K
Change In working capital 161.85%3.26M259.15%8.11M-49.99%1.85M73.68%-10.51M19.01%-3.84M64.87%-5.27M66.01%-5.09M171.01%3.69M-361.81%-39.93M-336.17%-4.74M
-Change in receivables 8.73%-6.25M187.03%5.92M-30.06%4.24M62.86%-7.33M103.30%263K-79.51%-6.85M1.82%-6.8M683.33%6.06M-59.65%-19.74M-1,006.11%-7.96M
-Change in inventory 288.35%3.56M46.12%4.43M249.72%4.77M124.28%4.29M236.15%6.33M63.57%-1.89M135.91%3.03M46.16%-3.19M-149.76%-17.65M184.48%1.88M
-Change in prepaid assets -413.33%-2.61M214.34%3.47M-2,050.74%-2.93M50.86%-9.52M-65.91%-7.18M113.07%833K29.68%-3.03M96.87%-136K-209.69%-19.36M-246.16%-4.33M
-Change in payables and accrued expense 284.64%7.86M-52.03%-5.31M-292.65%-3.98M-111.31%-1.06M-144.86%-1.68M336.85%2.04M-211.78%-3.49M-38.03%2.07M-12.96%9.33M-54.11%3.73M
-Change in other current liabilities -17.28%-1.06M23.24%-436K24.88%-794K-78.50%-3.41M9.88%-885K-35.79%-903K-24.56%-568K-653.40%-1.06M48.23%-1.91M81.49%-982K
-Change in other working capital 17.86%1.76M-99.31%40K1,206.12%542K-30.72%6.52M-123.88%-696K-21.23%1.5M186.07%5.77M-101.90%-49K-6.00%9.41M-13.63%2.92M
Cash from discontinued investing activities
Operating cash flow 411.89%13.22M317.68%6.2M38.45%3.96M143.18%5.28M53.59%9.51M43.51%-4.24M69.81%-2.85M293.11%2.86M-364.17%-12.23M13.67%6.19M
Investing cash flow
Cash flow from continuing investing activities -136.66%-15.81M-27.53%2.02M96.59%-5.75M-67.94%-93.89M156.92%29.07M3,849.91%43.12M195.71%2.79M-21,550.51%-168.87M-166.32%-55.91M-179.10%-51.06M
Net PPE purchase and sale 25.56%-990K25.59%-977K-12.28%-567K52.32%-4.65M77.03%-1.5M-19.82%-1.33M1.13%-1.31M35.26%-505K-123.37%-9.75M-403.86%-6.53M
Net intangibles purchase and sale 112.70%8K-169.09%-148K---55K-49.17%-179K23.75%-61K-57.50%-63K---55K--0---120K---80K
Net business purchase and sale --0--0--0---45.13M---1K---1K--0---45.13M--0--0
Net investment purchase and sale -133.31%-14.83M-24.31%3.15M95.84%-5.13M4.57%-43.94M168.90%30.63M--44.52M362.00%4.16M---123.24M---46.04M---44.45M
Cash from discontinued investing activities
Investing cash flow -136.66%-15.81M-27.53%2.02M96.59%-5.75M-67.94%-93.89M156.92%29.07M3,849.91%43.12M195.71%2.79M-21,550.51%-168.87M-166.32%-55.91M-179.10%-51.06M
Financing cash flow
Cash flow from continuing financing activities -46.05%-12.08M-892.13%-1.71M1.61M-858.43%-41.81M-976.73%-33.75M-5,438.06%-8.27M-81.12%216K0-97.42%5.51M22,547.06%3.85M
Net issuance payments of debt 2.17%-135K-0.71%-142K959.59%1.26M-119.26%-565K-104.77%-140K---138K---141K---146K205.81%2.93M--2.93M
Net common stock issuance -41.79%-11.95M-----------44.15M---34.74M---8.43M----------0--0
Proceeds from stock option exercised by employees -66.67%147K-15.04%1.23M149.26%506K19.15%3.32M24.49%1.23M95.13%441K19.65%1.45M-44.23%203K334.42%2.79M5,711.76%988K
Net other financing activities 2.01%-146K-17.12%-130K-159.65%-148K-100.48%-419K-43.66%-102K-109.86%-149K---111K---57K---209K---71K
Cash from discontinued financing activities
Financing cash flow -46.05%-12.08M-892.13%-1.71M--1.61M-858.43%-41.81M-976.73%-33.75M-5,438.06%-8.27M-81.12%216K--0-97.42%5.51M22,547.06%3.85M
Net cash flow
Beginning cash position 35.25%177.92M27.76%169.14M-44.03%167.63M-17.86%299.5M-52.09%163.63M-62.40%131.54M-63.48%132.39M-17.86%299.5M119.49%364.62M-9.36%341.52M
Current changes in cash -147.93%-14.67M4,076.28%6.52M99.89%-184K-108.26%-130.43M111.76%4.82M460.17%30.61M101.39%156K-8,656.12%-166.02M-131.76%-62.63M-219.70%-41.02M
Effect of exchange rate changes -163.98%-943K324.85%2.26M255.50%1.7M41.99%-1.45M17.86%-823K1,051.56%1.47M28.19%-1.01M-404.63%-1.09M-291.17%-2.49M-247.79%-1M
End cash Position -0.81%162.3M35.25%177.92M27.76%169.14M-44.03%167.63M-44.03%167.63M-52.09%163.63M-62.40%131.54M-63.48%132.39M-17.86%299.5M-17.86%299.5M
Free cash flow 316.94%12.22M218.61%5M41.73%3.34M102.05%454K2,006.71%7.95M34.92%-5.63M60.83%-4.22M204.12%2.35M-8,407.89%-22.1M-110.04%-417K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+3.16%
Halozyme Therapeutics
HALO
+2.31%
Teradata Corp
TDC
+1.49%
Cars.com
CARS
+0.86%
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+0.74%

Unlock the Full List